Dermatology OTC medicines are directly sold by pharmacies and drug stores without the prescription from the physicians, as opposed to the drugs prescribed and maybe only sold to consumers who hold a valid prescription.
Johnson and Johnson Services, Inc. and GlaxoSmithkline plc – Notable Market Players in Dermatology OTC Medications Market
Market leaders operating in the market have undertaken various organic growth strategies in the Dermatology OTC Medications market. The Dermatology OTC Medications market majorly consists of the players such as Bausch Health Companies Inc.; Perrigo Company plc; Bayer AG; Viatris Inc.; Johnson and Johnson Services, Inc.; LEO Pharma A/S; GlaxoSmithKline plc.; Galderma; Dr. Reddy’s Laboratories; and Acella Pharmaceuticals, LLC. The companies have been implementing various strategies that have helped the growth of the company and in turn have brought about various changes in the market. The companies have utilized organic strategies such as launches, expansion, and product approvals. Moreover, the companies have utilized inorganic strategies including mergers & acquisitions, partnership, and collaboration.
Below is the list of the growth strategies done by the players operating in the dermatology OTC medications market:
| Company | Month & Year | Category | Description |
| Perrigo company plc | Aug’20 | Mergers and Acquisitions | Perrigo Company plc a leading global provider of quality, affordable self-care products, announced that it acquired three Eastern European OTC skincare and hair loss treatment brands (Emolium, Iwostin and Loxon) from Sanofi. |
| Viatris Inc. | Jul-2019 | Mergers and Acquisitions | Mylan N.V. and Pfizer Inc. entered into an agreement to combine Mylan with Upjohn, Pfizer’s off-patent branded and generic established medicines business, creating a new global pharmaceutical company. Under the terms of the agreement, Pfizer shareholders would own 57% of the combined new company, and Mylan shareholders would own 43%. |
Source: The Insight Partners Analysis, Website, Press Releases and Others
